Lidocaine 5% patch 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F73BE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,138
Award facts
- Contract value 100% obligated
- $13,138.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Lidocaine 5% Patch 30S, a topical anesthetic product commonly used for localized pain relief in military and federal healthcare settings. This firm fixed-price delivery order carries a ceiling value of $13,138.20 and is set to be completed by December 16, 2025. The contract represents a non-set-aside, competitively awarded procurement, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements through open competition. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, continues to serve as a critical vendor within the federal medical supply chain through this delivery order. The company's substantial IDC with DLA enables the delivery of a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's role in supporting military healthcare logistics and demonstrates the flexibility of DLA's pharmaceutical prime vendor approach for fulfilling distributed federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F73BE?
SPE2DR26F73BE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F73BE worth?
The government has obligated $13,138 on SPE2DR26F73BE.
Is contract SPE2DR26F73BE an order under another contract?
Yes. SPE2DR26F73BE is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73BE competed?
The extent of competition for SPE2DR26F73BE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award